Thymoquinone (TQ) regulates cyclooxygenase-2 expression and prostaglandin E2 production through PI3kinase (PI3K)/p38 kinase pathway in human breast cancer cell line, MDA-MB-231

Animal Cells and Systems

Volumn 16, Issue 4, 2012, Pages 274-279

  Yu, Seon Mi ^a   Kim, Song Ja ^a  

^a Kongju National University   (South Korea)

Author keywords

cyclooxygenase 2 (COX 2); MDA MB 231; prostaglandin E 2 (PGE 2); thymoquinone (TQ)

Indexed keywords

EID: 84865253814     PISSN: 19768354     EISSN: 21512485     Source Type: Journal    
DOI: 10.1080/19768354.2011.647834     Document Type: Article

References (21)

1. Ali, BH and Blunden, G. 2003. Pharmacological and toxicological properties of Nigella sativa. Phytother Res, 17: 299-305.
2. Cao, Z, Liu, LZ, Dixon, DA, Zheng, JZ, Chandran, B and Jiang, BH. 2007. Insulin-like growth factor-I induces cyclooxygenase-2 expression via PI3K, MAPK and PKC signaling pathways in human ovarian cancer cells. Cell Signal, 19: 1542-1553.
3. Costa, C, Soares, R, Reis-Filho, JS, Leitao, D, Amendoeira, I and Schmitt, FC. 2002. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol, 55: 429-434.
4. El Mezayen, R, El Gazzar, M, Nicolls, MR, Marecki, JC, Dreskin, SC and Nomiyama, H. 2006. Effect of thymoquinone on cyclooxygenase expression and prostaglandin production in a mouse model of allergic airway inflammation. Immunol Lett, 106: 72-81.
5. Gali-Muhtasib, H, Roessner, A and Schneider-Stock, R. 2006. Thymoquinone: A promising anti-cancer drug from natural sources. Int J Biochem Cell Biol, 38: 1249-1253.
6. Jemal, A, Siegel, R, Xu, J and Ward, E. 2010. Cancer statistics, 2010. CA Cancer J Clin, 60: 277-300.
7. Lin, HY, Sun, M, Tang, HY, Simone, TM, Wu, YH, Grandis, JR, Cao, HJ, Davis, PJ and Davis, FB. 2008. Resveratrol causes COX-2- and p53-dependent apoptosis in head and neck squamous cell cancer cells. J Cell Biochem, 104: 2131-2142.
8. O'Banion, MK. 1999. Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol, 13: 45-82.
9. Park, K, Han, S, Shin, E, Kim, HJ and Kim, JY. 2006. Cox-2 expression on tissue microarray of breast cancer. Eur J Surg Oncol, 32: 1093-1096.
10. Ravindran, J, Nair, HB, Sung, B, Prasad, S, Tekmal, RR and Aggarwal, BB. 2010. Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential. Biochem Pharmacol, 79: 1640-1647.
11. Schneider, A and Stahl, RA. 1998. Cyclooxygenase-2 (COX-2) and the kidney: current status and potential perspectives. Nephrol Dial Transplant, 13: 10-12.
12. Shoieb, AM, Elgayyar, M, Dudrick, PS, Bell, JL and Tithof, PK. 2003. In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone. Int J Oncol, 22: 107-113.
13. Smith, WL, DeWitt, DL and Garavito, RM. 2000. Cyclooxygenases: structural, cellular, and molecular biology. Ann Rev Biochem, 69: 145-182.
14. Smith, WL, Garavito, RM and DeWitt, DL. 1996. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. Critical Rev neurobiol, 271: 33157-33160.
15. Stasinopoulos, I, Mori, N and Bhujwalla, ZM. 2008. The malignant phenotype of breast cancer cells is reduced by COX-2 silencing. Neoplasia, 10: 1163-1169.
16. St-Germain, ME, Gagnon, V, Mathieu, I, Parent, S and Asselin, E. 2004. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells. Int J Oncol, 24: 1311-1324.
17. Takeda, K, Kanekura, T and Kanzaki, T. 2004. Negative feedback regulation of phosphatidylinositol 3-kinase/Akt pathway by over-expressed cyclooxygenase-2 in human epidermal cancer cells. J Dermatol, 31: 516-523.
18. Velho-Pereira R, Kumar A, Pandey BN, Jagtap AG, Mishra KP. 2011. Radiosensitization in human breast carcinoma cells by thymoquinone: role of cell cycle and apoptosis. Cell Biol Int. 35: 1025-1029.
19. Yang, T, Huang, Y, Heasley, LE, Berl, T, Schnermann, JB and Briggs, JP. 2000. MAPK mediation of hypertonicity-stimulated cyclooxygenase-2 expression in renal medullary collecting duct cells. J Biol Chem, 275: 23281-23286.
20. Yoon, JH, Lim, TG, Lee, KM, Jeon, AJ, Kim, SY and Lee, KW. 2011. Tangeretin reduces ultraviolet B (UVB)-induced cyclooxygenase-2 expression in mouse epidermal cells by blocking mitogen-activated protein kinase (MAPK) activation and reactive oxygen species (ROS) generation. J Agric Food Chem, 59: 222-228.
21. Ziegler, RG, Hoover, RN, Pike, MC, Hildesheim, A, Nomura, AM, West, DW, Wu-Williams, AH, Kolonel, LN, Horn-Ross, PLRosenthal, JF. 1993. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst, 85: 1819-1827.